Like what you read? Get new posts delivered straight to your inbox!
Contact Us | Follow Us
Experience. Integrity. IMPACT.
What We Do

BJ Witkin Promoted to Senior Manager, Regulatory Operations

RESEARCH TRIANGLE PARK, NC: 17 August 2015 – On August 15th of 2015, BJ Witkin was promoted to Senior Manager, Regulatory Operations, at Impact Pharmaceutical Services, Inc. (IMPACT).

Since joining IMPACT in May of 2013, BJ has been instrumental in the development and growth of the electronic publishing services that IMPACT provides to their customers. Electronic publishing was a new service that IMPACT deployed in 2013 and the client base for these services has continued to grow over the last 18 months. In addition, BJ has extensive experience as a Certified Microsoft Trainer and these skills have become a valued service that IMPACT provides to clients. Many of IMPACT’s clients are virtual or small pharmaceutical companies who frequently need assistance with Microsoft Word or with the use of authoring templates that are needed to write regulatory documents for Investigational New Drug applications (INDs) or New Drug Applications (NDAs). BJ has a real passion for helping others and excels at training. His training services have become a very valuable service that IMPACT provides to their clients and is a service that many CROs do not offer.

According to Tim Garver, IMPACT Executive Vice President and COO, “We are so pleased to have BJ as part of the IMPACT family. He is a top-notch publisher and trainer who has an outstanding reputation among his colleagues within and outside of IMPACT. BJ brings a sincere enthusiasm to work each and every day, which is an attitude that both his co-workers and his clients greatly appreciate. This promotion to Senior Manager, Regulatory Operations is very well-deserved.”

IMPACT is a Contract Research Organization (CRO) located in Research Triangle Park, NC. Our team consists of drug development professionals who specialize in medical writing and quality control, drug development consulting, regulatory affairs, regulatory operations, project and program management, and early phase clinical trial management.

Media Contact:
Mark A. Cierpial, PhD, Chief Executive Officer
Phone: (919) 899-9248
Fax: (919) 354-6090